Cancer Incidence and Mortality among Non-Hispanic Whites, New York City, 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 18110.8 501.7 498.3-505.1 8791.2 522.4 517.4-527.4 9319.6 495.7 490.9-500.5 5112.4 127.8 126.2-129.5 2496.8 144.4 141.9-147.0 2615.6 116.7 114.5-118.8
Oral cavity and pharynx 400.0 11.1 10.6-11.6 268.6 16.0 15.2-16.9 131.4 6.7 6.2-7.2 77.6 2.0 1.8-2.2 52.6 3.1 2.7-3.5 25.0 1.1 0.9-1.3
Esophagus 141.2 3.7 3.4-4.0 103.2 6.0 5.5-6.6 38.0 1.7 1.5-2.0 99.8 2.6 2.3-2.8 73.0 4.2 3.8-4.7 26.8 1.1 1.0-1.4
Stomach 284.6 7.7 7.3-8.1 164.0 9.8 9.1-10.5 120.6 6.0 5.5-6.5 128.4 3.3 3.0-3.6 76.4 4.5 4.0-5.0 52.0 2.3 2.0-2.6
Colorectal 1419.8 38.8 37.9-39.8 734.4 44.3 42.9-45.8 685.4 34.3 33.1-35.5 475.2 11.7 11.2-12.2 234.6 13.6 12.8-14.4 240.6 10.3 9.7-10.9
Colon excluding rectum 1013.8 27.2 26.4-28.0 512.8 30.7 29.5-32.0 501.0 24.3 23.3-25.4 387.8 9.4 9.0-9.9 188.8 10.8 10.2-11.6 199.0 8.4 7.9-9.0
Rectum & rectosigmoid 406.0 11.6 11.1-12.2 221.6 13.6 12.8-14.4 184.4 9.9 9.3-10.6 87.4 2.3 2.1-2.5 45.8 2.8 2.4-3.2 41.6 1.9 1.6-2.2
Liver / intrahepatic bile duct 293.8 7.7 7.3-8.1 205.2 11.8 11.1-12.6 88.6 4.2 3.8-4.6 190.6 4.9 4.5-5.2 122.8 7.1 6.5-7.7 67.8 3.0 2.7-3.4
Pancreas 565.4 14.4 13.9-15.0 279.2 16.3 15.4-17.2 286.2 12.8 12.1-13.5 437.6 10.8 10.3-11.3 219.0 12.6 11.9-13.4 218.6 9.3 8.7-9.9
Larynx 102.4 2.8 2.5-3.0 85.0 5.0 4.5-5.5 17.4 0.9 0.7-1.1 29.4 0.8 0.6-0.9 24.0 1.4 1.2-1.7 5.4 0.2 0.2-0.4
Lung and bronchus 2059.0 53.1 52.1-54.2 980.6 57.0 55.4-58.6 1078.4 50.5 49.1-51.9 1086.6 27.0 26.3-27.7 543.0 31.3 30.1-32.5 543.6 23.7 22.8-24.7
Melanoma of the skin 815.8 22.9 22.2-23.7 463.2 28.1 26.9-29.3 352.6 19.1 18.2-20.1 66.8 1.8 1.6-2.0 39.8 2.4 2.1-2.7 27.0 1.3 1.1-1.5
Female breast             2710.4 153.9 151.1-156.6             407.4 19.0 18.2-20.0
Cervix uteri             110.2 7.1 6.5-7.7             28.4 1.6 1.4-2.0
Corpus uterus and NOS             645.2 34.2 33.0-35.5             123.8 5.7 5.2-6.2
Ovary             241.6 13.3 12.5-14.1             155.6 7.5 6.9-8.0
Prostate       1971.2 111.8 109.6-114.1             252.0 14.2 13.4-15.0      
Testis       127.4 8.8 8.1-9.6             2.0 0.1 0.1-0.2      
Urinary bladder (incl. in situ) 987.2 25.3 24.6-26.0 747.4 43.5 42.1-45.0 239.8 11.1 10.4-11.8 178.8 4.1 3.8-4.4 127.2 7.1 6.6-7.7 51.6 2.0 1.7-2.3
Kidney and renal pelvis 614.8 17.5 16.9-18.1 410.2 24.9 23.8-26.0 204.6 10.9 10.2-11.6 106.4 2.7 2.4-2.9 71.4 4.1 3.7-4.6 35.0 1.5 1.3-1.8
Brain and other central nervous system 256.4 8.1 7.6-8.6 141.0 9.3 8.6-10.0 115.4 7.0 6.4-7.7 145.2 4.1 3.8-4.4 78.8 4.8 4.3-5.3 66.4 3.5 3.1-3.9
Thyroid 780.0 25.8 25.0-26.7 214.8 14.2 13.3-15.1 565.2 37.5 36.1-39.0 21.0 0.5 0.4-0.6 8.2 0.5 0.3-0.7 12.8 0.5 0.4-0.7
Hodgkin lymphoma 110.4 3.8 3.5-4.1 61.4 4.3 3.8-4.9 49.0 3.2 2.8-3.7 10.6 0.3 0.2-0.4 7.0 0.4 0.3-0.6 3.6 0.2 0.1-0.3
Non-Hodgkin lymphomas 893.4 24.8 24.1-25.6 482.6 29.5 28.3-30.8 410.8 20.9 19.9-21.9 190.6 4.7 4.4-5.0 106.0 6.2 5.7-6.8 84.6 3.5 3.1-3.9
Myeloma 275.4 7.2 6.8-7.6 156.0 9.1 8.5-9.8 119.4 5.6 5.2-6.1 91.4 2.3 2.1-2.5 50.6 2.9 2.6-3.3 40.8 1.8 1.5-2.1
Leukemias 635.0 17.6 16.9-18.2 365.4 22.3 21.3-23.4 269.6 13.6 12.8-14.4 227.2 5.7 5.3-6.0 121.2 7.1 6.6-7.7 106.0 4.7 4.2-5.1

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.